PMC:7152526 / 4751-5248 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"116","span":{"begin":186,"end":193},"obj":"Species"},{"id":"134","span":{"begin":446,"end":449},"obj":"Gene"},{"id":"135","span":{"begin":454,"end":458},"obj":"Gene"},{"id":"136","span":{"begin":397,"end":404},"obj":"Species"},{"id":"140","span":{"begin":355,"end":361},"obj":"Chemical"},{"id":"141","span":{"begin":335,"end":340},"obj":"Disease"}],"attributes":[{"id":"A116","pred":"tao:has_database_id","subj":"116","obj":"Tax:9606"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Gene:1401"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"Gene:3569"},{"id":"A136","pred":"tao:has_database_id","subj":"136","obj":"Tax:9606"},{"id":"A140","pred":"tao:has_database_id","subj":"140","obj":"MESH:D010100"},{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"MESH:D005334"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.\nThe fever subsided, and oxygen demand decreased since day 11. The patient's condition much improved with decreased CRP and IL-6 to normal range (5.7 mg/L and \u003c 1.5 pg"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T33","span":{"begin":88,"end":91},"obj":"Body_part"},{"id":"T34","span":{"begin":128,"end":134},"obj":"Body_part"},{"id":"T35","span":{"begin":323,"end":329},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":" ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.\nThe fever subsided, and oxygen demand decreased since day 11. The patient's condition much improved with decreased CRP and IL-6 to normal range (5.7 mg/L and \u003c 1.5 pg"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T44","span":{"begin":74,"end":76},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0017178"}],"text":" ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.\nThe fever subsided, and oxygen demand decreased since day 11. The patient's condition much improved with decreased CRP and IL-6 to normal range (5.7 mg/L and \u003c 1.5 pg"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T61","span":{"begin":128,"end":134},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T62","span":{"begin":323,"end":329},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T63","span":{"begin":389,"end":391},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T64","span":{"begin":495,"end":497},"obj":"http://purl.obolibrary.org/obo/CLO_0008426"}],"text":" ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.\nThe fever subsided, and oxygen demand decreased since day 11. The patient's condition much improved with decreased CRP and IL-6 to normal range (5.7 mg/L and \u003c 1.5 pg"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T30","span":{"begin":355,"end":361},"obj":"Chemical"},{"id":"T31","span":{"begin":454,"end":456},"obj":"Chemical"}],"attributes":[{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A32","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":" ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.\nThe fever subsided, and oxygen demand decreased since day 11. The patient's condition much improved with decreased CRP and IL-6 to normal range (5.7 mg/L and \u003c 1.5 pg"}

{"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":124,"end":215},"obj":"Sentence"},{"id":"T42","span":{"begin":216,"end":252},"obj":"Sentence"},{"id":"T43","span":{"begin":253,"end":330},"obj":"Sentence"},{"id":"T44","span":{"begin":331,"end":392},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.\nThe fever subsided, and oxygen demand decreased since day 11. The patient's condition much improved with decreased CRP and IL-6 to normal range (5.7 mg/L and \u003c 1.5 pg"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T12","span":{"begin":335,"end":340},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":" ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.\nThe fever subsided, and oxygen demand decreased since day 11. The patient's condition much improved with decreased CRP and IL-6 to normal range (5.7 mg/L and \u003c 1.5 pg"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T90","span":{"begin":12,"end":19},"obj":"BV_9"},{"id":"T91","span":{"begin":88,"end":91},"obj":"GO:0071735"},{"id":"T92","span":{"begin":128,"end":134},"obj":"UBERON:0001969"},{"id":"T93","span":{"begin":323,"end":329},"obj":"UBERON:0001969"},{"id":"T94","span":{"begin":454,"end":458},"obj":"PR:000001393"},{"id":"T97911","span":{"begin":12,"end":19},"obj":"BV_9"},{"id":"T23659","span":{"begin":88,"end":91},"obj":"GO:0071735"},{"id":"T34586","span":{"begin":128,"end":134},"obj":"UBERON:0001969"},{"id":"T2920","span":{"begin":323,"end":329},"obj":"UBERON:0001969"},{"id":"T21491","span":{"begin":454,"end":458},"obj":"PR:000001393"}],"text":" ELISA kit; Epitope Diagnostics, San Diego, CA, USA) and optical density (OD) ratio for IgG was 0.586 (cut-off value 0.22). The plasma was divided into two doses and administered to the patient at 12 hours interval. Each dose was given over for 1 hour. No adverse reaction occurred after the administration of convalescent plasma.\nThe fever subsided, and oxygen demand decreased since day 11. The patient's condition much improved with decreased CRP and IL-6 to normal range (5.7 mg/L and \u003c 1.5 pg"}